SOX9 and neoplasm: Taken together, these results suggest that germline risk alleles at 17q24 promote ERG-mediated changes in SOX9 expression only in TMPRSS2:ERG fusion-positive tumors, and the synergistic effect of these factors—risk variants and TMPRSS2:ERG fusion—render advantages to precursor cells in tumor formation.